Extensive Surgical Wound Lavage Reduces the Incidence and Severity of Heterotopic Ossification in Primary Total Hip Replacement: A Study of 175 Hip Replacements

por Kantak, Avadhoot P., Shah, Nirav N.
Publicado 2017

CAR T-cell therapy for secondary CNS DLBCL

por Ahmed, Gulrayz, Hamadani, Mehdi, Shah, Nirav N.
Publicado 2021

Bispecific Chimeric Antigen Receptor T Cell Therapy for B Cell Malignancies and Multiple Myeloma

por Cronk, Robert J., Zurko, Joanna, Shah, Nirav N.
Publicado 2020

Multi Targeted CAR-T Cell Therapies for B-Cell Malignancies

por Shah, Nirav N., Maatman, Theresa, Hari, Parameswaran, Johnson, Bryon
Publicado 2019

Mimicking Myelodysplastic Syndrome: Importance of Differential Diagnosis

por Luo, Thomas, Zurko, Joanna, Astle, John, Shah, Nirav N.
Publicado 2021

Leukemic phase and CSF involvement of diffuse large B‐cell lymphoma with a complex karyotype including a TP53 deletion

por Sinkoff, Jillian, Olteanu, Horatiu, Peterson, Jess F., Shah, Nirav N.
Publicado 2017

Gut microbiome and CAR-T therapy

por Abid, Muhammad Bilal, Shah, Nirav N., Maatman, Theresa C., Hari, Parameswaran N.
Publicado 2019

Salvage polatuzumab and allogeneic transplant rescue patients with B-cell lymphoma failing CAR T-cell therapy

por Furqan, Fateeha, Maring, Morgan, Szabo, Aniko, Fenske, Timothy S., Hamadani, Mehdi, Shah, Nirav N.
Publicado 2022

Bone Marrow Aplasia after CAR-T-Cell Therapy for Relapsed/Refractory Burkitt’s Lymphoma

por Kenkel, Troy J., Sridhar, Nithya, Hammons, Lindsay R., Hintzke, Maria, Shah, Nirav N.
Publicado 2023

PD-1 blockade after bispecific LV20.19 CAR T modulates CAR T-cell immunophenotype without meaningful clinical response

por Zurko, Joanna, Chaney, Katherine, Astle, John M., Johnson, Bryon D., Hari, Parameswaran, Shah, Nirav N.
Publicado 2021

P1082: RESULTS FROM A PHASE 1/2 STUDY OF TANDEM, BISPECIFIC ANTI-CD20/ANTI-CD19 (LV20.19) CAR T-CELLS FOR MANTLE CELL LYMPHOMA

por Shah, Nirav N, Fenske, Timothy, Johnson, Bryon, Szabo, Aniko, Devata, Sumana, Longo, Walter, Kearl, Tyce, Zamora, Anthony, Hari, Parameswaran, Schneider, Dina, Hamadani, Mehdi
Publicado 2023

Phase I/II trial of bendamustine, ixazomib, and dexamethasone in relapsed/refractory multiple myeloma

por Dhakal, Binod, D’Souza, Anita, Hamadani, Mehdi, Arce-Lara, Carlos, Schroeder, Katrina, Chhabra, Saurabh, Shah, Nirav N., Gauger, Katelyn, Keaton, Taylor, Pasquini, Marcelo, Hari, Parameswaran
Publicado 2019

Long-term outcomes of rituximab, temozolomide and high-dose methotrexate without consolidation therapy for lymphoma involving the CNS

por Nagle, Sarah J, Shah, Nirav N, Ganetsky, Alex, Landsburg, Daniel J, Nasta, Sunita D, Mato, Anthony, Schuster, Stephen J, Reshef, Ran, Tsai, Donald E, Svoboda, Jakub
Publicado 2017

The role of FDG-PET imaging as a prognostic marker of outcome in primary mediastinal B-cell lymphoma

por Nagle, Sarah J, Chong, Elise A, Chekol, Seble, Shah, Nirav N, Nasta, Sunita D, Glatstein, Eli, Plastaras, John P, Torigian, Drew A, Schuster, Stephen J, Svoboda, Jakub
Publicado 2015

Associations between socioeconomic status and bispecific LV20.19 CAR T-cell therapy outcomes

por Knight, Jennifer M., Hackett, Edward, Szabo, Aniko, Wu, Ruizhe, Sauber, Garrett, Johnson, Bryon, Cusatis, Rachel N., Aughey, Elizabeth, Cole, Steve W., Hillard, Cecilia J., Shah, Nirav N.
Publicado 2022

Efficacy of a third SARS-CoV-2 mRNA vaccine dose among hematopoietic cell transplantation, CAR T cell, and BiTE recipients

por Abid, Muhammad Bilal, Rubin, Micah, Ledeboer, Nathan, Szabo, Aniko, Longo, Walter, Mohan, Meera, Shah, Nirav N., Fenske, Timothy S., Abedin, Sameem, Runaas, Lyndsey, D’Souza, Anita, Chhabra, Saurabh, Dhakal, Binod, Hamadani, Mehdi
Publicado 2022

P618: LONG-TERM SAFETY WITH ≥12 MONTHS OF PIRTOBRUTINIB IN RELAPSED/REFRACTORY (R/R) B-CELL MALIGNANCIES

por Jurczak, Wojciech, Coombs, Catherine C., Shah, Nirav N., Woyach, Jennifer, Cheah, Chan Y., Patel, Krish, Maddocks, Kami, Wang, Yucai, E. Muehlenbein, Catherine, Wang, Chunxiao, Abhyankar, Sarang, Tsai, Donald E., Eyre, Toby A.
Publicado 2023

Rap1A, Rap1B, and β-Adrenergic Signaling in Autologous HCT: A Randomized Controlled Trial of Propranolol

por Johnson, Alexander K., Lorimer, Ellen L., Szabo, Aniko, Wu, Ruizhe, Shah, Nirav N., D’Souza, Anita, Chhabra, Saurabh, Hamadani, Mehdi, Dhakal, Binod, Hari, Parameswaran, Rao, Sridhar, Carlson, Karen, Williams, Carol L., Knight, Jennifer M.
Publicado 2022

Patient-reported outcomes and neurotoxicity markers in patients treated with bispecific LV20.19 CAR T cell therapy

por Knight, Jennifer M., Szabo, Aniko, Arapi, Igli, Wu, Ruizhe, Emmrich, Amanda, Hackett, Edward, Sauber, Garrett, Yim, Sharon, Johnson, Bryon, Hari, Parameswaran, Schneider, Dina, Dropulic, Boro, Cusatis, Rachel N., Cole, Steve W., Hillard, Cecilia J., Shah, Nirav N.
Publicado 2022

S224: HIGH COMPLETE RESPONSE RATE WITH TNB-486, A NOVEL CD19XCD3 T-CELL ENGAGER, IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: INTERIM RESULTS FROM AN ONGOING PHASE 1 STUDY

por Jacobs, Ryan, Nair, Ranjit, Cho, Seok-Goo, Devata, Sumana, Gaballa, Sameh, Yoon, Dok Hyun, Stevens, Don, Kim, Jin Seok, Shah, Nirav N, Brennan, Denise Marie, Law, Jason, Lesley, Robin, Chen, Rob, Forcina, Alessandra, Buelow, Ben, Hou, Jing-Zhou
Publicado 2023